Sanjeev Nanda, a British-Indian entrepreneur based in Dubai has invested in ISHVAN Pharmaceuticals Ltd to develop the pharmaceutical infrastructure of Russia. The company will focus on bringing in inexpensive and innovative medical drugs and devices to new pharmaceutical markets. Cipla, Laurus, and Myla are some of the Indian companies that have entered into negotiations with ISHVAN for this initiative.
Showing posts with label ishvan_pharmaceuticals. Show all posts
Showing posts with label ishvan_pharmaceuticals. Show all posts
Thursday, 14 May 2020
Subscribe to:
Posts (Atom)
-
Sachin Dev Duggal and his college mate Saurav Dhoot. Duggal, a serial entrepreneur, holds an engineering degree from Imperial College, L...
-
China has been unkind to the U.S. Internet giants Google, Facebook and Amazon.com. But as a growing China spurs demand for foreign...
-
Darren Huston says that ten years from now, no paper work will be involved in the travel. “You’ll have no passport, no credit cards, no conf...
